Photo from isomorphiclabs.com ↗Profile · isomorphiclabs.com ↗

Sarah Skerratt

Now Chief Research Officer, Isomorphic Labs

Latest on AI4S.fyiTimeline · Jan 20Isomorphic Labs signs a multi-target drug-design deal with Johnson & Johnson across modalities, large-molecule and biologics design included: Isomorphic designs in silico, J&J runs the assays

Photos come from each person's X account, their own site, lab or team page, a conference page that lists them as a speaker in the same role, or Wikimedia Commons under the licence credited, so some may be out of date. Anyone can ask for theirs to be replaced or removed. Contact →

Affiliations

Current

Chief Research Officer · Isomorphic Labsas of 2026-10-07isomorphiclabs.com ↗

Current roles come from these dated records, not from the bio below. Each links the page it was read from.

On the timeline

2026-01-20Isomorphic Labs signs a multi-target drug-design deal with Johnson & Johnson across modalities, large-molecule and biologics design included: Isomorphic designs in silico, J&J runs the assays

Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →